Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Psychiatry and Mental health,Clinical Neurology
Reference84 articles.
1. Baldwin DS, Ajel K, Masdrakis VG, et al. Pregabalin for the treatment of generalized anxiety disorder: an update. Neuropsychiatr. 2013;9:883–92.
2. Katzman MA. Current considerations in the treatment of generalized anxiety disorder. CNS Drugs. 2009;23(2):103–20.
3. Both C, Kojda G, Lange-Asschenfeldt C. Pharmacotherapy of generalized anxiety disorder: focus and update on pregabalin. Expert Rev Neurother. 2014;14(1):29–38.
4. Brown TA, O’Leary TA, Barlow DH. Chapter 4. Generalized anxiety disorder. In: Barlow DH, editor. Clinical handbook of psychological disorders. 3rd ed. New York: Guilford Press; 2001. p. 154–208. http://commonweb.unifr.ch/artsdean/pub/gestens/f/as/files/4660/21992_121827.pdf . Accessed 28 Apr 2014.
5. Hoffman DL, Dukes EM, Wittchen HU. Human and economic burden of generalized anxiety disorder. Depress Anxiety. 2008;25(1):72–90.
Cited by
83 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献